Prelude Therapeutics (PRLD) Other Gross PP&E Adjustments (2024 - 2025)

Historic Other Gross PP&E Adjustments for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to -$27.5 million.

  • Prelude Therapeutics' Other Gross PP&E Adjustments rose 559.59% to -$27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.5 million, marking a year-over-year increase of 559.59%. This contributed to the annual value of -$32.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Prelude Therapeutics reported Other Gross PP&E Adjustments of -$27.5 million as of Q3 2025, which was up 559.59% from -$27.9 million recorded in Q2 2025.
  • Prelude Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at -$27.5 million during Q3 2025, with a 5-year trough of -$32.0 million in Q4 2024.